Depression treatment and coronary artery disease outcomes: Time for reflection

Journal of Psychosomatic Research

Volumn 74, Issue 1, 2013, Pages 4-5

  Shapiro, Peter A ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ACUTE CORONARY SYNDROME; CLINICAL RESEARCH; COGNITIVE THERAPY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HUMAN; ICD-10; LONG TERM CARE; MAJOR DEPRESSION; MENTAL PATIENT; MORTALITY; OUTCOME ASSESSMENT; PSYCHOSOMATICS; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SURGICAL PATIENT; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; JOURNAL IMPACT FACTOR; PERIODICALS AS TOPIC; PSYCHOSOMATIC MEDICINE; RESEARCH;

EID: 84871689008     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2012.11.008     Document Type: Editorial

References (23)

1. Zuidersma M., Conradi H.J., van Melle J.P., Ormel J., de Jonge P. Depression treatment after myocardial infarction and long-tem risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res 2013, 74:25-30. (this issue).
2. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JGP, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822.
3. Writing Committee for the ENRICHD Investigators Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. J Am Med Assoc 2003, 289:3106-3116.
4. de Jonge P, Honig A, van Melle JP, Schene AH, Kuyper AMG, Tulner D, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007, 164:1371-1378.
5. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AMG, Crijns HJGM, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007, 190:460-466.
6. Honig A, Kuyper AMG, Schene AH, van Melle JP, de Jonge P, Tulner DM, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007, 69:606-613.
7. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JTJ, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. J Am Med Assoc 2002, 288:701-709.
8. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006, 63:283-288.
9. Glassman AH, Bigger JT, Gaffney M Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009, 66:1022-1029.
10. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, Burg MM, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005, 62:792-798.
11. Carney RM, Freedland KE Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009, 166:410-417.
12. Strik JJMH, Honig A, Lousberg R, Lousberg AHP, Cheriex EC, Tuynman-Qua HG, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000, 62:783-789.
13. Lesperance F, Frasure-Smith N, Koszycki D, Laliberte M-A, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. J Am Med Assoc 2007, 297:367-379.
14. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. J Am Med Assoc 2009, 302:2095-2103.
15. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010, 170:600-608.
16. Dickens C, McGowan L, Percival C, Tomenson B, Cotter L, Heagerty A, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 2008, 70:450-455.
17. Parker GB, Hilton TM, Walsh WF, Owen CA, Heruc GA, Olley A, et al. Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol Psychiatry 2008, 64:660-666.
18. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003, 362:604-609.
19. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2010, 40:807-814.
20. Linke SE, Rutledge T, Johnson BD, Vaccarino V, Bittner V, Cornell CE, et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 2009, 66:499-507.
21. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C Depression is associated with increased mortality 10years after coronary artery bypass surgery. Psychosom Med 2010, 72:874-881.
22. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. J Am Med Assoc 2008, 300:2161-2171.
23. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007, 131:446-452.